Inactive Instrument

News BioLargo, Inc. OTC Bulletin Board

Equities

US09065A1007

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

06-11	BioLargo, Inc. Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-Ion	CI
05-14	Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BioLargo, Inc. Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-Ion	06-11	CI
Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024	05-14
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024	04-02
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
BioLargo to Present at The LD Micro Invitational XIV	03-25	NE
New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready	02-22	AQ
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors	02-12	CI
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment	01-29	CI
BioLargo, Inc. announced that it has received $0.815 million in funding	01-22	CI
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey	12-20	CI
BioLargo, Inc. cancelled the transaction announced on December 13, 2022	12-12	CI
Transcript : BioLargo, Inc., Q3 2023 Earnings Call, Nov 20, 2023	11-20
BioLargo, Inc. announced that it expects to receive $0.815 million in funding	11-16	CI
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
BioLargo, Inc. to Present at the LD Micro Main Event XVI	23-09-19	NE
Transcript : BioLargo, Inc., Q2 2023 Earnings Call, Aug 16, 2023	23-08-16
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
BioLargo, Inc. Discusses Record-Breaking Financial Results, Innovation-Pipeline Business Model, and More with The Stock Day Podcast	23-06-05	NE
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BioLargo, Inc. OTC Bulletin Board

Equities

US09065A1007

Summary

Filters